Warm dye may ease pain during key fertility exam
NCT ID NCT07226310
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether warming the contrast dye used in a hysterosalpingogram (HSG) — a standard X-ray test for blocked fallopian tubes — can reduce pain and cramping during the procedure. About 240 women aged 18–45 will be randomly assigned to receive either warm or room-temperature dye. The goal is to see if warm dye leads to less discomfort and fewer false signs of blockage, which can happen when the tubes spasm from the cold liquid.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
warmed contrast dye
What this could lead to
If it works, this could make a common fertility test less painful and more accurate by reducing false blockages.
What could go wrong
This is a very early, small trial. Warming the dye may not meaningfully reduce pain or improve test results, and the effect may vary from person to person.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Oklahoma Health Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact